Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Mostrar otras versiones (1)

BACKGROUND: Robust biomarkers that identify prostate cancer patients with high risk of recurrence will improve personalised cancer care. In this study, we investigated whether tissue metabolites detectable by high-resolution magic angle spinning magnetic resonance spectroscopy (HR-MAS MRS) were asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729443/
https://www.ncbi.nlm.nih.gov/pubmed/28972967
http://dx.doi.org/10.1038/bjc.2017.346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729443/
https://www.ncbi.nlm.nih.gov/pubmed/28972967
http://dx.doi.org/10.1038/bjc.2017.346

Ejemplares similares